Challenges in CNS drug development and the role of imaging.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Works matching IS 00333158 AND DT 2021 AND VI 238 AND IP 5
Results: 15
1
2
Association between functional brain alterations and neuropsychological scales in male chronic smokers using resting-state fMRI.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1387, doi. 10.1007/s00213-021-05819-6
- By:
- Publication type:
- Article
3
Alprazolam-induced EEG spectral power changes in rhesus monkeys: a translational model for the evaluation of the behavioral effects of benzodiazepines.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1373, doi. 10.1007/s00213-021-05793-z
- By:
- Publication type:
- Article
4
Smoking-related cue reactivity in a virtual reality setting: association between craving and EEG measures.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1363, doi. 10.1007/s00213-020-05733-3
- By:
- Publication type:
- Article
5
Altered fronto-occipital connectivity during visual selective attention in regular cannabis users.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1351, doi. 10.1007/s00213-020-05717-3
- By:
- Publication type:
- Article
6
Evaluation of dopamine D3 receptor occupancy by blonanserin using [11C]-(+)-PHNO in schizophrenia patients.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1343, doi. 10.1007/s00213-020-05698-3
- By:
- Publication type:
- Article
7
No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1333, doi. 10.1007/s00213-020-05693-8
- By:
- Publication type:
- Article
8
Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1265, doi. 10.1007/s00213-019-05448-0
- By:
- Publication type:
- Article
9
Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1255, doi. 10.1007/s00213-019-05427-5
- By:
- Publication type:
- Article
10
Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1315, doi. 10.1007/s00213-019-05407-9
- By:
- Publication type:
- Article
11
The potential of 1H-MRS in CNS drug development.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1241, doi. 10.1007/s00213-019-05344-7
- By:
- Publication type:
- Article
12
Choline elevation in amygdala region at recovery indicates longer survival without depressive episode: a magnetic resonance spectroscopy study.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1303, doi. 10.1007/s00213-019-05303-2
- By:
- Publication type:
- Article
13
Computational approaches and machine learning for individual-level treatment predictions.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1231, doi. 10.1007/s00213-019-05282-4
- By:
- Publication type:
- Article
14
Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1291, doi. 10.1007/s00213-019-05192-5
- By:
- Publication type:
- Article
15
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 5, p. 1279, doi. 10.1007/s00213-018-5134-y
- By:
- Publication type:
- Article